RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 editor 6 months ago editor
![](data:image/svg+xml;charset=utf-8,<svg height="1024" width="1024" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="100" width="100" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
